Your session is about to expire
← Back to Search
NUsurface Meniscus Implant for Osteoarthritis and Post-Meniscectomy Pain Syndrome (SUN Trial)
SUN Trial Summary
This trial is designed to test the safety and probable clinical benefit of the NUsurface® Meniscus Implant in patients who have had prior knee surgery.
- Osteoarthritis
- Post-Meniscectomy Pain Syndrome
SUN Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SUN Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- The back part of your meniscus is completely torn.You have a medial meniscal rim that is at least 2 mm thick and can be fitted with a NUsurface® device.You have a knee problem caused by a tear that can be fixed with surgery, but there needs to be at least 4 mm of the rim of your medial meniscus left after the surgery.You have a knee that cannot bend properly and is stuck in a straight position.You have a condition where your knee cap is not aligned properly or is unstable, causing pain or discomfort.You have any kind of knee joint disease that causes inflammation, like Sjogren's syndrome.You cannot receive corticosteroid injections if you are allergic to any of its ingredients or have a condition called idiopathic thrombocytopenic purpura.You have received corticosteroid knee injections within the last three months before starting the study treatment.You have a knee deformity that causes your knee to bend inward or outward by more than 5 degrees, and you may need surgery to correct it.You have had a knee replacement surgery with a specific type of artificial knee implant made of non-resorbable materials like plastic, metal, or ceramic, except for the NUsurface® Meniscus Implant.You cannot bend your joint more than 90 degrees.You are currently smoking cigarettes.You have problems with your nerves that affect your senses, movement, or reflexes.You have a condition called neuropathic knee osteoarthropathy, also known as Charcot joint.You have a KOOS Pain of ≤ 75 (100 being the highest attainable and no pain).You have a body mass index (BMI) higher than 32.5 when you start the study treatment.You are considering getting a specific type of knee surgery called allograft medial meniscus transplantation.You had a surgery to fix your ACL (a ligament in your knee) less than 9 months ago.Your leg bones are straight when measured from the hip to the ankle.
- Group 1: NUsurface Meniscus Implant
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who is the ideal candidate for this medical research project?
"This clinical trial seeks 115 patients aged between 30 and 75 years old, who suffer from knee osteoarthritis. The KOOS Pain score of the patient should not exceed 75 (100 being no pain) and they must have a neutral alignment ±5º of the mechanical axis, as measured by specific anatomical markers."
Are participants still being accepted for this trial?
"The clinicaltrials.gov portal reveals that this medical trial, which was posted on the 1st of December 2015 and last updated on the 18th February 2022 is no longer recruiting candidates. However, there are 456 other studies actively enrolling participants at present."
Does the age limit of seventy years or older disqualify individuals from participating in this investigation?
"According to the stipulations of this clinical trial, prospective participants must be between 30-75 years old. Additionally, there are 27 trials for minors and 433 specifically tailored towards elderly individuals."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger